sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 576-600 out of 1320.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>

Public Release: 7-Jan-2016
The Lancet Infectious Diseases
Current malaria treatment fails in Cambodia due to drug-resistant parasites
New findings from NIAID confirm dihydroartemisinin-piperaquine, the first-line treatment for Plasmodium falciparum malaria infection in Cambodia, has failed in certain provinces due to parasite resistance to artemisinin and piperaquine. Additional study findings suggest that artesunate, a form of artemisinin, plus mefloquine, a different long-acting partner drug, should be the first-line ACT in areas where dihydroartemisinin-piperaquine treatment has failed, the study authors note.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 6-Jan-2016
Journal of Medical Entomology
Love hertz
James Cook University researchers have found sex sells when it comes to luring male mosquitoes.

Contact: Alistair Bone
James Cook University

Public Release: 6-Jan-2016
TTUHSC researcher receives NIH grant for vaccine
Texas Tech University Health Sciences Center researcher Afzal A. Siddiqui, Ph.D., a Grover E. Murray Distinguished Professor at the TTUHSC School of Medicine, received a $3.82 million grant from the National Institutes of Health. The three-year NIAID/SBIR-R44 Phase II Grant is to prepare the Schistosomiasis Vaccine (SchistoShield®) for human clinical trials. This phase of the research funding is in collaboration with Darrick Carter, president and CEO of PAI Life Science in Seattle, WA.
National Institutes of Health

Contact: Suzanna Cisneros
Texas Tech University Health Sciences Center

Public Release: 6-Jan-2016
Walter Reed Army Institute of Research begins phase 2 clinical trial of Ebola vaccine
The Walter Reed Army Institute of Research (WRAIR) today began a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers.
Joint Vaccines Acquisition Program at the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense

Contact: Lisa Reilly
The U.S. Military HIV Research Program (MHRP)

Public Release: 5-Jan-2016
Academic Medicine
Do no harm: Examining the impact of medical students' short-term international study
International study experiences are a valuable and increasingly expected part of medical students' academic experience, but authors of a new article in Academic Medicine say not all programs leave patients and communities better off. They have recommendations for choosing effective programs and also for shifting the focus to ensure the programs are beneficial for all.

Contact: Peter Bothum
University of Delaware

Public Release: 5-Jan-2016
Journal of Virology
Study shows high frequency of spontaneous mutation in Ebola virus
In a Journal of Virology paper, Texas Biomed Scientist Dr. Anthony Griffiths, explains how he and his team found that Ebola virus has the potential to evolve rapidly but the genetic changes result in viruses that are weakened or not viable, which could be exploited as a therapeutic.

Contact: Lisa Cruz
Texas Biomedical Research Institute

Public Release: 4-Jan-2016
Could bug-busting viruses control food poisoning?
Viruses that can seek and destroy food poisoning bugs in the gut are being investigated by researchers at The University of Nottingham, thanks to a prestigious new grant.
Bill and Melinda Gates Foundation

Contact: Emma Thorne
University of Nottingham

Public Release: 31-Dec-2015
PLOS Neglected Tropical Diseases
Areas of increased poverty associated with higher rates of Ebola transmission
Since October 2014 the Ebola epidemic in West Africa has been diminishing and efforts have shifted from emergency response to prevention and mitigation of future outbreaks.
National Science Foundation, National Institutes of Health

Contact: Mosoka P Fallah

Public Release: 24-Dec-2015
Cell Reports
'Self-sabotage' prevents immune protection against malaria
Australian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itself against the disease. The discovery opens up the possibility of improving new or existing malaria vaccines by boosting key immune cells needed for long-lasting immunity. This could even include vaccines that have previously been ineffective in clinical trials.
National Health and Medical Research Council, Australian Research Council, Sylvia and Charles Viertel Charitable Foundation, Victorian Government Operational Infrastructure Support Program

Contact: Liz Williams
Walter and Eliza Hall Institute

Public Release: 23-Dec-2015
SIAM Journal on Applied Mathematics
New SIR-Network Model helps predict dengue fever epidemic in urban areas
An article 'SIR-Network Model And its Application to Dengue Fever,' authored by Lucas M. Stolerman, Daniel Coombs and Stefanella Boatto, published recently in the SIAM Journal on Applied Mathematics introduces a new mathematical model which offers a simplified approach to studying the spread of the infectious virus, Dengue fever, in urban areas, specifically breaking down the epidemic dynamics across a city and its varying neighborhoods and populations.

Contact: Becky Kerner
215-382-9800 x383
Society for Industrial and Applied Mathematics

Public Release: 23-Dec-2015
Lancet Global Health
In China, training doctors reduced STI risk
Results of a randomized, controlled clinical trial in two Chinese provinces show that providing sexually transmitted infection training and education for physicians resulted in significantly reduced infection risk among their patients.
National Institutes of Health

Contact: David Orenstein
Brown University

Public Release: 22-Dec-2015
Nature Communications
NUS researchers uncover potent parasite-killing mechanism of anti-malarial drug
A team of researchers from the National University of Singapore has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.

Contact: Goh Yu Chong
National University of Singapore

Public Release: 22-Dec-2015
International Journal of Risk & Safety in Medicine
Towards the rational use of medicines
Rational use of medicines remains to be one of the most challenging problems in health systems worldwide. Kazan Federal University researchers conducted a practical study to assess the impact of introducing evidence-based principles to the practice of medicine procurement in order to manage budget expenditures on medicines of a multidisciplinary health facility for the period of 2011-2014.

Contact: Yevgeniya Litvinova
Kazan Federal University

Public Release: 22-Dec-2015
Lancet Infectious Diseases
Largest study of Ebola survivors finds vision, hearing, joint pain problems
The largest study of survivors of the largest recorded outbreak of Ebola virus disease found they commonly reported complications such as vision, hearing and joint pain problems up to months after they were discharged from an Ebola treatment facility.
Canadian Institutes of Health Research

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 22-Dec-2015
PLOS Medicine
South Africa's child mortality reduction deemed 'a successful failure'
As the 25-year period for the UN Millennium Development Goals concludes on Dec. 31, 2015, to be replaced by the Sustainable Development Goals, a deeper analysis of factors outside defined goals is necessary to learn why some countries failed. This is an argument presented by researchers at Umea University in an article published today in the scientific journal PLOS Medicine.

Contact: Daniel Harju
Umea University

Public Release: 18-Dec-2015
HIV identified as leading risk factor for stroke in young African adults
HIV infection is the leading risk factor for stroke in young African adults, a new study by the University of Liverpool's Institute of Infection and Global Health has found.
Wellcome Trust, Medical Research Council, National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections

Contact: Nicola Frost
University of Liverpool

Public Release: 17-Dec-2015
Going viral: Could peroxisomes be key to stopping West Nile and Dengue viruses?
A new discovery from the University of Alberta's Faculty of Medicine & Dentistry could open the door to one day treat or prevent diseases caused by West Nile virus and Dengue virus infections. Together the viruses are the cause of tens of millions of infections each year. Currently there are no treatments or vaccines available.
Alberta Innovates: Health Solutions, Canadian Institutes of Health Research, Canada Research Chairs

Contact: Ross Neitz
University of Alberta Faculty of Medicine & Dentistry

Public Release: 17-Dec-2015
US and Mexico must work to prevent future outbreaks of mosquito-transmitted diseases
Despite the increasing risks of mosquito-transmitted epidemics in the United States and Mexico, policymakers in both countries have made little effort to prevent future outbreaks, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

Contact: Jeff Falk
Rice University

Public Release: 17-Dec-2015
La Jolla Institute for Allergy and Immunology team receives $18 million consortium grant
The La Jolla Institute for Allergy and Immunology (LJI) is pleased to announce that an international team led by LJI investigator Alessandro Sette, Ph.D., is one of four recipients of a Human Immune Profiling Consortium (HIPC) grant in 2015. With this prestigious grant, the LJI team will characterize the immune response to dengue virus (DENV) and Mycobacterium tuberculosis (TB), both of which represent major global health challenges.
National Institutes of Health

Contact: Gina Kirchweger
La Jolla Institute for Allergy and Immunology

Public Release: 17-Dec-2015
Social Science and Medicine
Top risk factors for child undernutrition in India identified
In India, nearly 40 percent of all children are stunted -- of extremely low height for their age -- and nearly 30 percent are underweight. A new study from Harvard T.H. Chan School of Public Health has now pinpointed the five top risk factors responsible for more than two-thirds of the problem.

Contact: Marge Dwyer
Harvard T.H. Chan School of Public Health

Public Release: 16-Dec-2015
$5 million in funding for research into malaria and tuberculosis drug discovery
University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly $12 million since 2012.

Contact: Heidi Singer
University of Toronto

Public Release: 15-Dec-2015
BMC Medicine
There's an app for that: An easy, fast and reliable way to record causes of death
Researchers have developed a revolutionary new app to capture accurate global cause of death data on tablets and mobile phones.

Contact: Jane Gardner
University of Melbourne

Public Release: 15-Dec-2015
PLOS Neglected Tropical Diseases
Rapid 'dipstick' test tackles fatal sleeping sickness
Scientists have developed a quick and simple diagnosis method, similar to a dipstick pregnancy test, to fight a deadly sleeping sickness. The test to diagnose Human African Trypanosomiasis (HAT) just requires a pin-prick blood sample and will remove the need to take complex equipment into remote areas of sub-Saharan Africa.
Biotechnology and Biological Sciences Research Council

Contact: Chris Melvin
Biotechnology and Biological Sciences Research Council

Public Release: 14-Dec-2015
Binghamton University professor launches web tool to track impact of drugs worldwide
Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.

Contact: Nicole Hassoun
Binghamton University

Public Release: 14-Dec-2015
Cancer Epidemiology, Biomarkers & Prevention
Cancer rates decline in many high-income countries, but rise in lower-income countries
Improved screening and detection efforts, combined with decreases in risk factors like smoking, have reduced the incidence and mortality rates from several common types of cancer in many high-income countries. However, many low- and middle-income countries have seen cancer rates rise, partially due to increases in risk factors that are typical of Western countries.
American Cancer Society

Contact: Lauren Riley
American Association for Cancer Research

Showing releases 576-600 out of 1320.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>